share_log

Monte Rosa Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Versant Venture Capital VI, L.P.(6.6%),Versant Ventures VI GP, L.P.(6.6%), etc.

Monte Rosa Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Versant Venture Capital VI, L.P.(6.6%),Versant Ventures VI GP, L.P.(6.6%)等

美股SEC公告 ·  2024/10/31 05:13
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息